Skip to content

13F-HR filed by Crestline Management, L.P.

Crestline Management, L.P. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 3 holding rows worth $53,476,000 by the sum of the rows.

Accession
0001315863-26-000592
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 3 entries on the cover page, a total value of $534,760,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $53,476,000 with VALUE read as dollars as filed, 13F file number 028-14917. The quarter's positions are built on this report. The resolved quarter.

The cover page states a total of $534,760,000, 900% more than the sum of the rows, $53,476,000. This page uses the sum of the rows.

Other managers

  • included managerRithm Capital Corp. 028-25604

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DENALI THERAPEUTICS INC COM24823R105Stock1,910,732$49,144,027dollars as filed
SANA BIOTECHNOLOGY INC799566104COM755,736$2,637,619dollars as filed
8X8 INC282914100COMMON STOCK990,850$1,694,354dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-26-000592this filing2026-08-14acceptance time not in the bulk data set